0001209191-20-049832.txt : 20200909
0001209191-20-049832.hdr.sgml : 20200909
20200909161230
ACCESSION NUMBER: 0001209191-20-049832
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200908
FILED AS OF DATE: 20200909
DATE AS OF CHANGE: 20200909
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Turner Leagh Erin
CENTRAL INDEX KEY: 0001746255
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38467
FILM NUMBER: 201166654
MAIL ADDRESS:
STREET 1: 228 DOUGLAS DRIVE
CITY: TORONTO
STATE: A6
ZIP: M4W 2C1
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ceridian HCM Holding Inc.
CENTRAL INDEX KEY: 0001725057
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372]
IRS NUMBER: 463231686
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3311 EAST OLD SHAKOPEE ROAD
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55425
BUSINESS PHONE: 952-853-8100
MAIL ADDRESS:
STREET 1: 3311 EAST OLD SHAKOPEE ROAD
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55425
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-09-08
0
0001725057
Ceridian HCM Holding Inc.
CDAY
0001746255
Turner Leagh Erin
C/O CERIDIAN HCM HOLDING INC.
3311 EAST OLD SHAKOPEE ROAD
MINNEAPOLIS
MN
55425
0
1
0
0
President and COO
Common Stock
2020-09-08
4
M
0
5000
38.63
A
126611
D
Common Stock
2020-09-08
4
S
0
1125
70.37
D
125486
D
Common Stock
2020-09-08
4
S
0
3054
71.36
D
122432
D
Common Stock
2020-09-08
4
S
0
821
72.62
D
121611
D
Option (right to purchase)
38.63
2020-09-08
4
M
0
5000
D
2028-09-04
Common Stock
5000
90000
D
Option (right to purchase)
49.93
2029-03-20
Common Stock
76335
76335
D
Option (right to purchase)
65.26
2030-05-08
Common Stock
187321
187321
D
Performance Units
2021-03-01
Common Stock
3382
3382
D
The sales reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.019 to $70.815 inclusive. The reporting person undertakes to provide Ceridian HCM Holding Inc., any security holder of Ceridian HCM Holding Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.05 to $71.97 inclusive. The reporting person undertakes to provide Ceridian HCM Holding Inc., any security holder of Ceridian HCM Holding Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.08 to $72.87 inclusive. The reporting person undertakes to provide Ceridian HCM Holding Inc., any security holder of Ceridian HCM Holding Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Includes (i) 25,000 shares issuable at the election of the recipient pursuant to vested Restricted Stock Units, granted on September 4, 2018, and 25,000 shares issuable pursuant to Restricted Stock Units that vest in two equal annual installments beginning on September 4, 2021, (ii) 50,000 shares that are issuable pursuant to Restricted Stock Units, granted on September 9, 2019, that vest in four equal annual installments beginning on September 9, 2020, (iii) 1,538 shares that are issuable pursuant to Restricted Stock Units, granted on February 28, 2020, that vest in three annual installments beginning on February 28, 2021, and (iv) 20,073 shares that are issuable pursuant to Restricted Stock Units, granted on May 8, 2020, that vest in three annual installments beginning on May 8, 2021.
Consists of 45,000 vested and exercisable options as of September 4, 2020, of which 5,000 are being exercised pursuant to a Rule 10b5-1 trading plan adopted by the reporting person, and 50,000 options that vest and become exercisable in two equal annual installments beginning on September 4, 2021.
Not applicable.
Consists of 19,083 vested and exercisable options as of March 20, 2020 and 57,252 options that vest and become exercisable in three annual installments beginning on March 20, 2021.
These options vest and become exercisable in four annual installments beginning on May 8, 2021.
Each performance unit, granted on February 28, 2020, represents a contingent right to receive up to 1.25 shares of Common Stock. The performance units vest upon satisfaction of Cloud Revenue and Adjusted EBITDA margin targets under the Company's 2020 Management Incentive Plan.
For Leagh Turner pursuant to the Power of Attorney previously filed.
/s/ William E. McDonald, attorney-in-fact
2020-09-09